Utilization of p53 and p16 Immunohistochemistry in the Classification of Human Papillomavirus–Associated, p53 Wild-Type, and p53 Abnormal Oral Epithelial Dysplasia
Modern Pathology · 2023-12 · 36 (12) · 100348
DOI: 10.1016/j.modpat.2023.100348 ↗Kurz gefasst
Fachartikel in der Zeitschrift Modern Pathology, 2023-12. Verfasst von Rachel Novack und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Human Papillomavirus Viruses, Papillomavirus Infections. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: University of British Columbia.
Abstract (Originalsprache)
p53 immunohistochemistry (IHC) has recently been shown to be a clinically useful marker for predicting risk of progression to invasive squamous cell carcinoma in oral epithelial dysplasia (OED). The literature supports the use of p53 IHC as a marker to identify TP53 mutation in in situ and invasive vulvar lesions and as a surrogate marker for high-risk human papillomavirus (HPV) infection, but there is little documentation for similar use in OED. The purpose of this study was to determine whether p53 IHC is a reliable surrogate marker for detecting both TP53 mutation and high-risk HPV infection in OED. We studied 57 cases of OED (11 mild, 18 moderate, and 28 severe), and all were stained for p16 and p53 IHC. High-risk HPV RNA in situ hybridization (ISH) was performed in selected cases (all p16-positive cases and all OED showing abundant apoptotic cells and karyorrhectic cells; N = 27). Targeted next-generation sequencing (NGS) was performed in 33 p16-negative cases and all high-risk HPV RNA ISH-negative cases (N = 36). We identified 21 cases with p53 basal sparing patterns (mid-epithelial and markedly reduced [null-like]), 14 cases with p53 wild-type patterns (scattered basal and patchy basal/parabasal), and 22 cases with p53 abnormal patterns (18 overexpression, 3 null, and 1 novel cytoplasmic pattern). Among cases with p53 basal sparing patterns, 20 were positive for p16 (20/21, 95%), and all were positive for high-risk HPV RNA ISH (21/21, 100%). The 36 sequenced cases had IHC patterns concordant with TP53 mutation status in 92% (33/36) of lesions. This study demonstrates that p53 IHC expression patterns are sensitive and specific for detection of both high-risk HPV infection and TP53 mutation. Coupled with selective p16 IHC testing, this IHC panel can accurately subclassify OED into HPV-associated, p53 wild-type (conventional), and p53 abnormal OED.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomical Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada.
- Department of Laboratory Medicine & Pathology, Faculty of Medicine & Dentistry, University of Alberta, Alberta, Canada.
- Department of Oral Biological and Medical Sciences, Faculty of Dentistry, University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Anatomical Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
- Department of Anatomical Pathology, Vancouver General Hospital, Vancouver, British Columbia, Canada; Department of Oral Biological and Medical Sciences, Faculty of Dentistry, University of British Columbia, Vancouver, B…
Förderung
- University of British Columbia
Zitieren
APA
Novack, R., Chapman, E., Gao, J., Horst, B., Hoang, L. N., Ng, T. L., & Ko, Y. C. K. (2023). Utilization of p53 and p16 Immunohistochemistry in the Classification of Human Papillomavirus–Associated, p53 Wild-Type, and p53 Abnormal Oral Epithelial Dysplasia. Modern Pathology, 36(12), 100348. https://doi.org/10.1016/j.modpat.2023.100348
Vancouver
Novack R, Chapman E, Gao J, Horst B, Hoang LN, Ng TL, et al. Utilization of p53 and p16 Immunohistochemistry in the Classification of Human Papillomavirus–Associated, p53 Wild-Type, and p53 Abnormal Oral Epithelial Dysplasia. Modern Pathology. 2023;36(12):100348. doi:10.1016/j.modpat.2023.100348
BibTeX
@article{Novack2023,
author = {Novack, Rachel and Chapman, Erin and Gao, Jiangyuan and Horst, Basil and Hoang, Lynn N and Ng, Tony L and Ko, Yen Chen Kevin},
title = {Utilization of p53 and p16 Immunohistochemistry in the Classification of Human Papillomavirus–Associated, p53 Wild-Type, and p53 Abnormal Oral Epithelial Dysplasia},
journal = {Modern Pathology},
year = {2023},
volume = {36},
number = {12},
pages = {100348},
doi = {10.1016/j.modpat.2023.100348}
}
EUVIMED